(Q81326073)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

VEGF receptor inhibition slows the progression of polycystic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

polycystic kidney disease

7 January 2020

main subject

1 reference

inferred from title

author

Robert William Schrier

8

object named as

Schrier RW

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Tao Y

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Kim J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Yin Y

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Zafar I

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Falk S

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

He Z

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Faubel S

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Edelstein CL

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

19 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1358-1366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17882148%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002550

7 January 2020

exact match

0 references

cites work

Vascular permeability factor, an endothelial cell mitogen related to PDGF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

c-myc as an inducer of polycystic kidney disease in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

VEGF as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

VEGF receptor 2 blockade leads to renal cyst formation in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Angiogenesis in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion cast study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Renal histology in polycystic kidney disease with incipient and advanced renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021

Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002550

7 January 2021